Blue Sparrow LLC’s Amgen AMGN Stock Holding History

Blue Sparrow LLC’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.8M	Buy	85,020 +80,000	+1,594%	+$27.4M	0.3%	58
2026 Q1	$1.77M	Sell	5,020 -27,392	-85%	-$9.77M	0.03%	134
2025 Q4	$10.6M	Buy	+32,412	New	+$10.3M	0.2%	65

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Blue Sparrow LLC's AMGN Position: Q2 2026 in Review

Blue Sparrow LLC increased its Amgen (AMGN) stake by 1,594% in Q2 2026, buying an estimated $27.4M and bringing the position to 85,020 shares worth $30.8M. The position accounts for 0.3% of the portfolio, ranked #58.

Blue Sparrow LLC first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Blue Sparrow LLC held 85,020 shares of Amgen worth $30.8M as of Q2 2026.
Blue Sparrow LLC bought 80,000 Amgen shares in Q2 2026, an estimated $27.4M.
Amgen made up 0.3% of Blue Sparrow LLC's portfolio in Q2 2026, its #58 holding.
Blue Sparrow LLC first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Blue Sparrow LLC's 13F filing for Q2 2026, filed 14 Aug 2026.